Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clearbridge Health Ltd. ( (SG:1H3) ) has shared an update.
Clearbridge Health Limited has announced its entry into a binding term sheet for the proposed acquisition of Elpis Biopharmaceuticals Pte. Ltd. This acquisition, if completed, will result in a reverse takeover of Clearbridge Health, subject to shareholder approval and due diligence. The deal is expected to enhance Clearbridge Health’s market positioning by integrating Elpis Biopharmaceuticals’ capabilities, potentially impacting stakeholders by expanding the company’s operational scope and market reach.
More about Clearbridge Health Ltd.
Clearbridge Health Limited is a healthcare company based in Singapore, focusing on providing medical services and healthcare solutions across Asia. The company operates through various subsidiaries, offering a range of healthcare services including diagnostics, precision medicine, and healthcare systems.
Technical Sentiment Signal: Buy
Current Market Cap: €4.36M
Find detailed analytics on 1H3 stock on TipRanks’ Stock Analysis page.